Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions
Year: 2015
Type: review
Abstract: Protein-protein interactions (PPIs) underlie the majority of biological processes, signaling, and disease. Approaches to modulate PPIs with small molecules have therefore attracted increasing interest over the past decade. However, there are a number of challenges inherent in developing small-molecule PPI inhibitors that have prevented these approaches from reaching their full potential. From target validation to small-molecule screening and lead optimization, identifying therapeutically relevant PPIs that can be successfully modulated by small molecules is not a simple task. Following the recent review by Arkin et al., which summarized the lessons learnt from prior successes, we focus in this article on the specific challenges of developing PPI inhibitors and detail the recent advances in chemistry, biology, and computation that facilitate overcoming them. We conclude by providing a perspective on the field and outlining four innovations that we see as key enabling steps for successful development of small-molecule inhibitors targeting PPIs.
Source: Chemistry & Biology
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $6,700
Awards: G1113157156, Enzyme regulation by allo-targeting: A strategic initiative for chemical biology and molecular therapeutics., Cambridge Condensed Matter Theory Programme Grant, G3529478126, Theory of Condensed Matter Group, Cambridge - Critical Mass Grant, Harnessing Our Understanding Of Water To Identify Druggable Protein Targets and Drive The Development Of Effective Therapeutics, Chromosomal instability in cancer pathogenesis and treatment, Restricted Diversity; Constrained Diversity-Oriented Synthesis, Therapeutic target discovery and validation programme & the systems microscopy initiative
OpenAlex ID: W1944929196
